Le Lézard
Classified in: Covid-19 virus
Subject: TRD

Fragrance Creators' Statement on Preventing $91 Million in Latest EU Essential Oils Tariffs

WASHINGTON, Jan. 12, 2021 /PRNewswire/ -- Fragrance Creators Association issued the following statement from Farah K. Ahmed, President & CEO, recognizing the United States Trade Representative (USTR) for declining to impose additional tariffs on essential oils as part of its latest EU Section 301 Boeing/Airbus Investigation:

"We recognize USTR for its decision not to impose additional tariffs on European essential oils in the latest round of tariffs related to the EU Section 301 Boeing/Airbus investigation. We also express our appreciation for USTR's willingness to share priorities and work with Fragrance Creators to find common ground to support U.S. consumers and the economy.

"Through direct engagement and education of USTR, the U.S. Department of Commerce, and Members of Congress, which included submitting written comments and testifying before USTR, Fragrance Creators has secured over $90 million in savings for the fragrance value chain. In recent years, the association has prevented over $180 million in essential oil tariffs. We appreciate that USTR understands the important role fragrance and the fragrance industry play in supporting American jobs, ensuring affordable scented products, and promoting quality of life and public health. For example, fragrance is a critical input into the cleaning, sanitizing, and disinfecting products needed to successfully combat the spread of COVID-19.

"Fragrance Creators looks forward to continuing to build relationships and advocate for the fragrance industry with the incoming Biden-Harris Administration and the Congressional Fragrance Caucus in order to drive solutions that support U.S. businesses and consumers."

Fragrance Creators Association is the principal fragrance trade association. The organization represents the majority of fragrance manufacturing in North America. The association also represents interests along the fragrance value chain. Fragrance Creators' membership is diverse, including companies that create, manufacture, and use fragrances and scents for home care, personal care, home design, fine fragrance, and industrial and institutional products as well as those that supply fragrance ingredients, including natural extracts and other raw materials that are used in perfumery and fragrance mixtures. Fragrance Creators produces The Fragrance Conservatorythe comprehensive digital resource for high-quality information about fragrance. Learn more about Fragrance Creators at fragrancecreators.org?for people, perfume, and the planet.


Lia Dangelico
Director, Communications
[email protected]

Related Images


Related Links

Fragrance Creators Association

The Fragrance Conservatory


SOURCE Fragrance Creators Association

These press releases may also interest you

21 jun 2024
Healthcare Trust, Inc. ("HTI") announced today that it intends to continue to pay dividends on a quarterly basis on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") at an annualized rate of...

21 jun 2024
Washington Federal Bank ("WaFd Bank" or the "Bank"), the wholly owned subsidiary of WaFd, Inc. (the "Company"), today announced the consummation of the sale of approximately $2.8 billion of multifamily commercial real estate loans ("CRE") to Bank of...

21 jun 2024
Surge Copper Corp. ("Surge" or the "Company") announces that it has closed its non-brokered private placement previously announced on June 6 and June 7, 2024, consisting of 8,966,668 special flow-through common shares (the "CFT Shares") at a price...

21 jun 2024
Natuzzi S.p.A. ("we", "Natuzzi" or the "Company" and, together with its subsidiaries, the "Group"), one of the most renowned brands in the production and distribution of design and luxury furniture, today reported its unaudited financial information...

21 jun 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that...

21 jun 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved FRUZAQLA (fruquintinib) as a monotherapy indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated...

News published on and distributed by: